Compare HALO & OSCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HALO | OSCR |
|---|---|---|
| Founded | 1998 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Accident &Health Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 7.1B |
| IPO Year | 2001 | 2021 |
| Metric | HALO | OSCR |
|---|---|---|
| Price | $74.99 | $29.79 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 8 |
| Target Price | ★ $78.64 | $16.88 |
| AVG Volume (30 Days) | 1.6M | ★ 6.9M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 1.22 | ★ 2.07 |
| Revenue | $151,862,000.00 | ★ $11,701,427,000.00 |
| Revenue This Year | $28.24 | $63.89 |
| Revenue Next Year | $12.56 | $5.30 |
| P/E Ratio | $59.53 | ★ $13.86 |
| Revenue Growth | N/A | ★ 27.50 |
| 52 Week Low | $51.06 | $10.69 |
| 52 Week High | $82.22 | $30.38 |
| Indicator | HALO | OSCR |
|---|---|---|
| Relative Strength Index (RSI) | 66.87 | 66.69 |
| Support Level | $62.53 | $12.01 |
| Resistance Level | $79.50 | N/A |
| Average True Range (ATR) | 2.20 | 1.78 |
| MACD | 0.30 | -0.07 |
| Stochastic Oscillator | 84.09 | 81.46 |
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.
Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.